Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Li, Yong  [Clear All Filters]
2019
Li, M.-X., Li, Q., Sun, X.-J., Luo, C., Li, Y., Wang, Y.-N., Chen, J., Gong, C.-Z., Li, Y.-J., Shi, L.-P., et al. (2019). Increased Homer1-mGluR5 mediates chronic stress-induced depressive-like behaviors and glutamatergic dysregulation via activation of PERK-eIF2α.Prog Neuropsychopharmacol Biol Psychiatry109682.
2018
Tang, M.-L., Bai, X.-J., Li, Y., Dai, X.-J., and Yang, F. (2018). MMP-1 Over-expression Promotes Malignancy and Stem-Like Properties of Human Osteosarcoma MG-63 Cells In Vitro.Curr Med Sci38, 809-817.
2016
Ma, Y., Han, F., Liang, J., Yang, J., Shi, J., Xue, J., Yang, L., Li, Y., Luo, M., Wang, Y., et al. (2016). A species-specific activation of Toll-like receptor signaling in bovine and sheep bronchial epithelial cells triggered by Mycobacterial infections.Mol Immunol71, 23-33.
Deng, J., Wang, L., Chen, H., Hao, J., Ni, J., Chang, L., Duan, W., Graham, P., and Li, Y. (2016). Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.Oncotarget.
2015
Chang, L., Graham, P., Hao, J., Ni, J., Deng, J., Bucci, J., Malouf, D., Gillatt, D., and Li, Y. (2015). Cancer stem cells and signaling pathways in radioresistance.Oncotarget.
Xiang, D., Shigdar, S., Qiao, G., Wang, T., Kouzani, A.Z., Zhou, S.-F., Kong, L., Li, Y., Pu, C., and Duan, W. (2015). Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine.Theranostics5, 23-42.
2014
Zhou, T., Ye, L., Bai, Y., Sun, A., Cox, B., Liu, D., Li, Y., Liotta, D., Snyder, J.P., Fu, H., et al. (2014). Autophagy and Apoptosis in Hepatocellular Carcinoma Induced by EF25-(GSH)2: A Novel Curcumin Analog.Plos One9, e107876.
Chatterjee, S., Yin, H., Nam, D., Li, Y., and Ma, K. (2014). Brain and muscle Arnt-like 1 promotes skeletal muscle regeneration through satellite cell expansion.Exp Cell Res.
2013
Niu, Q., Wang, W., Li, Y., Ruden, D.M., Li, Q., and Wang, F. (2013). Cisplatin in 5% Ethanol Eradicates Cisplatin-Resistant Lung Tumor by Killing Lung Cancer Side Population (SP) Cells and Non-SP Cells.Front Genet4, 163.